EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Placebo-Controlled Histamine Challenge Disproves Suspicion of Histamine Intolerance

Rebekka Karolin Bent, Claudia Kugler, Valentina Faihs, Ulf Darsow, Tilo Biedermann, Knut Brockow

The Journal of Allergy and Clinical Immunology: In Practice · 2023

DOI: 10.1016/j.jaip.2023.08.030 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2023. Verfasst von Rebekka Karolin Bent und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergy Biederstein, Faculty of Medicine, Technical University of Munich, Munich, Germany. Hauptthemen laut MEDLINE: Food Hypersensitivity, Amine Oxidase (Copper-Containing). Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Histamine intolerance (HIT) is frequently diagnosed in patients with polysymptomatic otherwise unexplained symptoms. OBJECTIVES: To exclude HIT by a single-blind placebo-controlled histamine challenge (SBPCHC), to study clinical features of patients with positive challenge, and to examine the predictability of HIT by biomarkers. METHODS: SBPCHC was performed in 59 patients with suspected HIT. History and clinical data, including serum diamine oxidase (DAO) and histamine skin test wheal size of patients with positive versus negative SBPCHC, were compared. RESULTS: Patients were predominantly middle-aged women (84.7%). Three-quarters reported improvement but never resolution of symptoms during a histamine-low diet. Histamine provocation was safe; only 1 patient was treated with antihistamines. Thirty-seven patients (62.7%) displayed symptoms to placebo. HIT was excluded in 50 patients (84.7%). Objective symptoms occurred in 4 of 59 cases (6.8%) after histamine but not after placebo challenge. These were diagnosed with "plausible HIT" because reactions occurring by chance could not be excluded. Another 5 patients (8.5%) were diagnosed with "possible HIT" after case-dependent detailed analysis. Patients with plausible/possible HIT had reported more gastrointestinal symptoms (P = .01), but comparable diet response and equal histamine skin prick test wheal sizes to those without HIT. Serum DAO activity tended to be lower in patients with HIT (P = .08), but was highly variable in those without, limiting its value as a biomarker. CONCLUSIONS: SBPCHC disproves HIT in the majority of patients. Placebo-controlled challenges are needed as placebo reactions were frequent. Gastrointestinal symptoms after food intake and reduced DAO levels are markers for HIT; however, specificity is not sufficient enough for making the diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Food HypersensitivityAmine Oxidase (Copper-Containing)Middle AgedHumansFemaleHistamineSingle-Blind MethodSkin TestsBiomarkers

Stichwörter der Autor:innen

Diamine oxidaseGastrointestinal symptomsHistamine intoleranceHistamine oral provocationSingle-blind placebo-controlled histamine challenge

Substanzen

HistamineAmine Oxidase (Copper-Containing)Biomarkers

Autor:innen und Institutionen

  • Department of Dermatology and Allergy Biederstein, Faculty of Medicine, Technical University of Munich, Munich, Germany.
  • Department of Dermatology and Allergy Biederstein, Faculty of Medicine, Technical University of Munich, Munich, Germany. Electronic address: Knut.brockow@tum.de.

Zitieren

APA

Bent, R. K., Kugler, C., Faihs, V., Darsow, U., Biedermann, T., & Brockow, K. (2023). Placebo-Controlled Histamine Challenge Disproves Suspicion of Histamine Intolerance. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2023.08.030

Vancouver

Bent RK, Kugler C, Faihs V, Darsow U, Biedermann T, Brockow K. Placebo-Controlled Histamine Challenge Disproves Suspicion of Histamine Intolerance. The Journal of Allergy and Clinical Immunology: In Practice. 2023. doi:10.1016/j.jaip.2023.08.030

BibTeX
@article{Bent2023,
  author = {Bent, Rebekka Karolin and Kugler, Claudia and Faihs, Valentina and Darsow, Ulf and Biedermann, Tilo and Brockow, Knut},
  title = {Placebo-Controlled Histamine Challenge Disproves Suspicion of Histamine Intolerance},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2023},
  doi = {10.1016/j.jaip.2023.08.030}
}
Kostenlos starten →